These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2739587)

  • 21. Comparative in vitro activities of four macrolides: josamycin, erythromycin, spiramycin and roxithromycin, against 424 anaerobic bacteria.
    Derriennic M; Dubreuil L; Reynaud AE; Courtieu AL
    Chemioterapia; 1987 Jun; 6(2 Suppl):159-60. PubMed ID: 3509376
    [No Abstract]   [Full Text] [Related]  

  • 22. Administration of antibiotics in combination. Determination of antibacterial effectivity of blood serum and urine after simultaneous administration of macrolides and tetracyclines.
    Janovska D; Vymola F; Godova T
    J Hyg Epidemiol Microbiol Immunol; 1976; 20(4):481-8. PubMed ID: 1035924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The effect of roxithromycin on the aerobic fecal flora in children].
    Borderon JC; Borderon E; Laugier J; Bremond M
    Pathol Biol (Paris); 1989 May; 37(5):353-7. PubMed ID: 2506510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The comparative in vitro activity of spiramycin and erythromycin against Norwegian bacterial isolates.
    Dibb WL; Ragnhildstveit E
    NIPH Ann; 1986 Dec; 9(2):61-3. PubMed ID: 3101004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative in vitro evaluation of the antimicrobial activity of flurithromycin by means of the MS-2 Abbott Research System.
    Periti P; Nicoletti P; Novelli A
    Chemioterapia; 1985 Apr; 4(2):156-60. PubMed ID: 3924422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intraphagocytic activity of erythromycin, roxithromycin and azithromycin.
    Milatovic D
    Eur J Clin Microbiol Infect Dis; 1990 Jan; 9(1):33-5. PubMed ID: 2154381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activity of midecamycin against Staphylococcus aureus.
    Peng CF; Chen TS
    Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1979 Mar; 12(1):32-3. PubMed ID: 583273
    [No Abstract]   [Full Text] [Related]  

  • 28. [Comparative in vitro activity of a new macrolide RU 28965 and of erythromycin against Chlamydia trachomatis].
    Dutilh B; de Barbeyrac B; Lafferrière C; Bébéar C
    Pathol Biol (Paris); 1986 May; 34(5):445-7. PubMed ID: 3534718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bovine pulmonary alveolar macrophages: antemortem recovery and in vitro evaluation of bacterial phagocytosis and killing.
    Trigo E; Liggitt HD; Breeze RG; Leid RW; Silflow RM
    Am J Vet Res; 1984 Sep; 45(9):1842-7. PubMed ID: 6497143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of cross resistance to erythromycin and carbomycin in Micrococcus pyogenes var. aureus.
    HSIE JY; KOTZ R; NUSSER W
    Antibiot Annu; 1955-1956; 3():773-7. PubMed ID: 13355361
    [No Abstract]   [Full Text] [Related]  

  • 31. [Bactericidal effects of macrophages of mice treated with interferon].
    Oishi K; Imanishi J; Kishida T
    C R Seances Soc Biol Fil; 1979; 173(5):1000-3. PubMed ID: 161179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative in vitro activity, serum binding and binding activity interactions of the macrolides A-56268, RU-28965, erythromycin and josamycin.
    Dette GA; Knothe H; Koulen G
    Drugs Exp Clin Res; 1987; 13(9):567-76. PubMed ID: 2962847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activities of amikacin, roxithromycin, and azithromycin alone or in combination with tumor necrosis factor against Mycobacterium avium complex.
    Bermudez LE; Young LS
    Antimicrob Agents Chemother; 1988 Aug; 32(8):1149-53. PubMed ID: 2847644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erythromycin, miocamycin and clindamycin towards adhesivity and phagocytosis of gram-positive bacteria.
    Mascellino MT; Catania S; De Vito ML; De Bac C
    Microbiologica; 1988 Jul; 11(3):231-41. PubMed ID: 3262809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sensitivity to spiramycin of thromycin-resistant strains of Staphylococcus aureus isolated from clinical sources.
    Whelan JP; Pugh IM
    Med J Aust; 1969 May; 1(22):1132-3. PubMed ID: 4893256
    [No Abstract]   [Full Text] [Related]  

  • 36. In vitro effects of four macrolides (roxithromycin, spiramycin, azithromycin [CP-62,993], and A-56268) on Toxoplasma gondii.
    Chang HR; Pechère JC
    Antimicrob Agents Chemother; 1988 Apr; 32(4):524-9. PubMed ID: 2837140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors affecting the in-vitro activity of roxithromycin.
    Andrews JM; Ashby JP; Wise R
    J Antimicrob Chemother; 1987 Nov; 20 Suppl B():31-7. PubMed ID: 3123452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibacterial activity of roxithromycin: a laboratory evaluation.
    Chantot JF; Bryskier A; Gasc JC
    J Antibiot (Tokyo); 1986 May; 39(5):660-8. PubMed ID: 3733515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [In vitro activity of josamycin in a comparison of Staphylococcus aureus, Streptococcus pyogenes and Streptococcus pneumoniae].
    Andreoni O
    Minerva Med; 1983 Mar; 74(12):619-24. PubMed ID: 6339995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cefonicid potentiation of human macrophage activity.
    Tullio V; Cuffini AM; Fazari S; Carlone NA
    Microbiologica; 1992 Jul; 15(3):219-26. PubMed ID: 1501583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.